Latka logo
BostonGene logo

BostonGenerevenue & acquisition

Clinical Decision SupportLincoln, MassachusettsFounded 2015

BostonGene was acquired.

BostonGene is an advanced biomedical software platform designed to support healthcare providers in tailoring precise immunological and targeted treatments that are personalized for each individual patient.

bostongene.comLinkedInUpdated Oct 5, 2026
Annual revenue
$114.8M
Dec 2023EST
Owner
Undisclosed
Date not on record
Employees
499
Dec 2023EST

BostonGene revenue

BostonGene has not published its revenue. Growjo puts it at about $114.8M a year (December 2023).

$0
$50M
$100M
$0
–
$114.8M
20152016–222023
ReportedEstimateFounded 2015 at $0; every reading has its own bar
As ofRevenueSource
Dec 2023$114.8MESTGrowjo estimate

Who owns BostonGene

Another company owns BostonGene. The date and price of the deal are not on record.

BostonGene CEO, founders & employees

Andrew Feinberg founded BostonGene in 2015 and led it as CEO. BostonGene had 499 employees (December 2023, Growjo estimate).

0
200
400
329
499
20222023
ReportedEstimateOne figure per year; a reported figure wins over an estimate
All 2 headcount readings, with sources
As ofEmployeesSource
Dec 2023499ESTGrowjo estimate
Dec 2022329ESTGrowjo estimate

BostonGene FAQ

What was BostonGene's revenue?

Growjo estimates BostonGene's revenue at about $114.8M a year (December 2023). The company hasn't published its own figure.

How many employees does BostonGene have?

Growjo estimates BostonGene's headcount at about 499 (December 2023).

Who founded BostonGene?

Andrew Feinberg founded BostonGene in 2015.

How this page is sourced

3 estimates. Founder figures link to the second they were said; public figures name their source; estimates are marked EST and say whose they are. Not financial advice.

Updated Oct 5, 2026Data disclaimerReport a correctionClaim this profileRun BostonGene? Join the podcast